Risk of Cancer in Patients with Myasthenia Gravis
- 1 May 1998
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 841 (1) , 742-745
- https://doi.org/10.1111/j.1749-6632.1998.tb11011.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Immunotherapy in neuromuscular disorders: Current and future strategiesMuscle & Nerve, 1996
- Risk of cancer from azathioprine therapy in multiple sclerosisNeurology, 1996
- Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patientsBlood, 1996
- Thymectomy and malignancyEuropean Journal of Cardio-Thoracic Surgery, 1994
- Long-Term Results of Corticosteroid Therapy in Patients with Myasthenia GravisEuropean Neurology, 1992
- Extrathymic malignancy in patients with myasthenia gravisEuropean Journal of Cancer and Clinical Oncology, 1991
- Cancers Complicating Organ TransplantationNew England Journal of Medicine, 1990
- A placebo‐controlled, randomized, double‐masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosisNeurology, 1989
- The Relationship Between Thymus and OncogenesisBritish Journal of Cancer, 1971